This research area includes a strong synthetic medicinal chemistry component involving the development of new synthetic methodologies to construct anti-infective, anti-cancer, and anti-viral agents. Faculty members also focus on drug metabolism and carcinogenesis, chemical toxicology, and neurochemistry. They are engaged in gene delivery system development, the identification of novel targets for anticancer agents, and the treatment of central nervous system disorders, as well as the discovery of novel pre-therapeutic lead molecules through the use of High Throughput Screening. Additionally, they achieve small molecule drug discovery is through structure-based drug design and computer-aided drug discovery, with a strong emphasis on enzyme drug targets.